Product References
Pitfalls and limitations of ZAP-70 detection in chronic lymphocytic leukemia.
Hematology (Amsterdam, Netherlands)
Vroblova V,Smolej L,Krejsek J
MA1-21350 was used in flow cytometry to discuss using flow cytometry to assess Zap-70 in chronic lymphocytic leukemia.
Sat Sep 01 00:00:00 EDT 2012
Cluster analysis of immunophenotypic data: the example of chronic lymphocytic leukemia.
Immunology letters
Zucchetto A,Cattarossi I,Nanni P,Zaina E,Prato G,Gilestro M,Marconi D,Bulian P,Rossi FM,Del Vecchio L,Omedè P,Geuna M,Del Poeta G,Gattei V
MA1-21350 was used in flow cytometry to identify the immunophenotypic signature of chronic lymphocytic leukemia subsets with different prognosis
Sun Jan 30 00:00:00 EST 2011
High expression of the immature laminin receptor protein correlates with mutated IGVH status and predicts a favorable prognosis in chronic lymphocytic leukemia.
Leukemia research
Friedrichs B,Siegel S,Reimer R,Barsoum A,Coggin J,Kabelitz D,Heidorn K,Schulte C,Schmitz N,Zeis M
MA1-21350 was used in flow cytometry to assess immature laminin receptor expression on patients with B cell malignancies
Wed Jun 01 00:00:00 EDT 2011
Methodological comparison of two anti-ZAP-70 antibodies.
Cytometry. Part B, Clinical cytometry
Degheidy HA,Venzon DJ,Farooqui MZ,Abbasi F,Arthur DC,Wilson WH,Wiestner A,Stetler-Stevenson MA,Marti GE
MA1-21350 was used in flow cytometry to discuss variance in the detection of ZAP-70 expression by clinical laboratories.
Thu Sep 01 00:00:00 EDT 2011
Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia.
Leukemia & lymphoma
Oliveira AC,de la Banda E,Domingo-Domenech E,Encuentra M,Mercadal S,Domingo A,Alonso E,Espinet B,Grau J,De Sevilla AF,Gonzalez-Barca E
MA1-21350 was used in flow cytometry to identify prognostic factors for chronic lymphocytic leukemia using a retrospective series.
Tue Mar 01 00:00:00 EST 2011
Quantitative analysis of protein phosphorylations and interactions by multi-colour IP-FCM as an input for kinetic modelling of signalling networks.
PloS one
Deswal S,Schulze AK,Höfer T,Schamel WW
MA1-21350 was used in flow cytometry to discuss how to study activation-dependent phosphorylation of proteins using mathematical modeling
Tue Dec 06 00:00:00 EST 2011
Recruitment of PKC-betaII to lipid rafts mediates apoptosis-resistance in chronic lymphocytic leukemia expressing ZAP-70.
Leukemia
zum Büschenfelde CM,Wagner M,Lutzny G,Oelsner M,Feuerstacke Y,Decker T,Bogner C,Peschel C,Ringshausen I
MA1-21350 was used in immunocytochemistry to investigate the contribution of ZAP-70 to chronic lymphocytic leukemia aggressiveness
Fri Jan 01 00:00:00 EST 2010
Significant change in ZAP-70 expression during the course of chronic lymphocytic leukemia.
European journal of haematology
Vroblova V,Vrbacky F,Hrudkova M,Jankovicova K,Schmitzova D,Maly J,Krejsek J,Smolej L
MA1-21350 was used in flow cytometry to examine expression of ZAP-70 throughout the disease course of chronic lymphocytic leukemia
Tue Jun 01 00:00:00 EDT 2010
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia.
Blood
Saddler C,Ouillette P,Kujawski L,Shangary S,Talpaz M,Kaminski M,Erba H,Shedden K,Wang S,Malek SN
MA1-21350 was used in flow cytometry to investigate chronic lymphocytic leukemia patient-derived samples' responses to MDM2 inhibitors and correlate responses with clinically important biomarkers
Fri Feb 01 00:00:00 EST 2008
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.
Blood
Li FJ,Ding S,Pan J,Shakhmatov MA,Kashentseva E,Wu J,Li Y,Soong SJ,Chiorazzi N,Davis RS
MA1-21350 was used in flow cytometry to assess the prognostic potential of Fc receptor-like molecules for chronic lymphocytic leukemia
Tue Jul 01 00:00:00 EDT 2008
Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
Haematologica
Gachard N,Salviat A,Boutet C,Arnoulet C,Durrieu F,Lenormand B,Leprêtre S,Olschwang S,Jardin F,Lafage-Pochitaloff M,Penther D,Sainty D,Reminieras L,Feuillard J,Béné MC
MA1-21350 was used in flow cytometry to determine ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia
Fri Feb 01 00:00:00 EST 2008
Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia.
Journal of immunology (Baltimore, Md. : 1950)
Friedrichs B,Siegel S,Kloess M,Barsoum A,Coggin J,Rohrer J,Jakob I,Tiemann M,Heidorn K,Schulte C,Kabelitz D,Steinmann J,Schmitz N,Zeis M
MA1-21350 was used in flow cytometry to test if the humoral immunity specific for the chronic lymphocytic leukemia-associated Ag oncofetal Ag/immature laminin receptor has a prognostic value in chronic lymphocytic leukemia
Thu May 01 00:00:00 EDT 2008
An improved flow cytometric method using FACS Lysing Solution for measurement of ZAP-70 expression in B-cell chronic lymphocytic leukemia.
Cytometry. Part B, Clinical cytometry
Bekkema R,Tadema A,Daenen SM,Kluin-Nelemans HC,Mulder AB
MA1-21350 was used in flow cytometry to describe an improved fluorescence-activate cell sorting lysing solution to measure ZAP-70 expression in B-cell chronic lymphocytic leukemia
Tue Jan 01 00:00:00 EST 2008
Optimization of flow cytometric measurement of ZAP-70 in chronic lymphocytic leukemia.
Cytometry. Part B, Clinical cytometry
Preobrazhensky SN,Bahler DW
MA1-21350 was used in flow cytometry to develop an optimized cell staining procedure for detection of zeta-chain associated protein-70 via flow cytometry
Sat Mar 01 00:00:00 EST 2008
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
Leukemia
Zanotti R,Ambrosetti A,Lestani M,Ghia P,Pattaro C,Remo A,Zanetti F,Stella S,Perbellini O,Prato G,Guida G,Caligaris-Cappio F,Menestrina F,Pizzolo G,Chilosi M
MA1-21350 was used in flow cytometry to discuss the use of ZAP-70 expression to identify patients with poor prognosis of chronic lymphocytic leukemia
Mon Jan 01 00:00:00 EST 2007
Familial B-cell chronic lymphocytic leukemia: analysis of cytogenetic abnormalities, immunophenotypic profiles, and immunoglobulin heavy chain gene usage.
American journal of clinical pathology
Aoun P,Zhou G,Chan WC,Page C,Neth K,Pickering D,Sanger W,Quinn-Laquer B,Watson P,Lynch JF,Lynch HT,Weisenburger DD
MA1-21350 was used in flow cytometry to study the cytogenetic, immunophenotypic, and VH gene usage characteristics of a family with B-cell chronic lymphocytic leukemia
Mon Jan 01 00:00:00 EST 2007
Modern prognostic factors and angiogenesis in chronic lymphocytic leukemia: more data needed.
Leukemia research
Smolej L,Andrys C,Vroblova V
MA1-21350 was used in flow cytometry to discuss prognostic factors ZAP-70, vascular endothelial growth factor and basic fibroblast growth factor and angiogenesis in chronic lymphocytic leukemia
Sat Dec 01 00:00:00 EST 2007
National standardization of ZAP-70 determination by flow cytometry: the French experience.
Cytometry. Part B, Clinical cytometry
Le Garff-Tavernier M,Ticchioni M,Brissard M,Salmon C,Raynaud S,Davi F,Bernard A,Merle-Béral H,Ajchenbaum-Cymbalista F,Letestu R
MA1-21350 was used in flow cytometry to report a simple, fast, and reproducible flow cytometry method to detect ZAP-70 expression
Thu Mar 01 00:00:00 EST 2007
Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells.
Blood
de Totero D,Meazza R,Zupo S,Cutrona G,Matis S,Colombo M,Balleari E,Pierri I,Fabbi M,Capaia M,Azzarone B,Gobbi M,Ferrarini M,Ferrini S
MA1-21350 was used in flow cytometry investigate IL-21 signaling in normal and chronic lymphocytic leukemia B cells
Mon May 01 00:00:00 EDT 2006
ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage.
Leukemia
Scielzo C,Camporeale A,Geuna M,Alessio M,Poggi A,Zocchi MR,Chilosi M,Caligaris-Cappio F,Ghia P
MA1-21350 was used in flow cytometry to investigate ZAP-70 expression in B-cell malignancies
Sat Apr 01 00:00:00 EST 2006
The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemia.
Cancer
Francis S,Karanth M,Pratt G,Starczynski J,Hooper L,Fegan C,Pepper C,Valcarcel D,Milligan DW,Delgado J
MA1-21350 was used in flow cytometry to discuss the features of patients with chronic lymphocytic leukemia and infections
Fri Sep 01 00:00:00 EDT 2006
A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
Journal of cellular physiology
Zucchetto A,Bomben R,Dal Bo M,Sonego P,Nanni P,Rupolo M,Bulian P,Dal Maso L,Del Poeta G,Del Principe MI,Degan M,Gattei V
MA1-21350 was used in flow cytometry describe an immunophenotypic scoring system for B-cell chronic lymphocytic leukemia
Mon May 01 00:00:00 EDT 2006
Feasibility of an easily applicable method of ZAP-70 measurement in chronic lymphocytic leukemia in the routine flow cytometry setting: A methodological approach.
Annals of hematology
Passam F,Tachynopoulou V,Skoumi D,Tsompanakou A,Stavropoulos-Giokas A,Vadikolia C,Anagnostopoulos A,Paterakis G
MA1-21350 was used in flow cytometry to use flow cytometry to assess the use of ZAP-70 expression as marker for B chronic lymphocytic leukemia
Wed Nov 01 00:00:00 EST 2006
A robust ratio metric method for analysis of Zap-70 expression in chronic lymphocytic leukemia (CLL).
Cytometry. Part B, Clinical cytometry
Bakke AC,Purtzer Z,Leis J,Huang J
MA1-21350 was used in flow cytometry to examine Zap-70 expression in patients with chronic lymphocytic leukemia
Sat Jul 15 00:00:00 EDT 2006
Comparison of methods for determining zeta-chain associated protein - 70 (ZAP-70) expression in patients with B-cell chronic lymphocytic leukemia (B-CLL).
Cytometry. Part B, Clinical cytometry
Bojarska-Junak A,Giannopoulos K,Kowal M,Dmoszyńska A,Roliński J
MA1-21350 was used in flow cytometry to investigate novel monoclonal antibodies to ZAP-70 to detect B-cell chronic lymphocytic leukemia
Sat Jul 15 00:00:00 EDT 2006
Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia.
Cytometry. Part B, Clinical cytometry
Sheridan R,Mounajjed T,Ehrmann DE,Hurtubise PE,Schrager JA
MA1-21350 was used in flow cytometry to compare bone marrow samples with peripheral blood for ZAP-70 expression in patients with chronic lymphocytic leukemia
Sat Jul 15 00:00:00 EDT 2006
ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.
Cytometry. Part B, Clinical cytometry
Zucchetto A,Bomben R,Bo MD,Nanni P,Bulian P,Rossi FM,Del Principe MI,Santini S,Del Poeta G,Degan M,Gattei V
MA1-21350 was used in flow cytometry to discuss the prognostic relevance and predictive power of ZAP-70 expression for patients with chronic lymphocytic leukemia
Sat Jul 15 00:00:00 EDT 2006
Clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemia.
Cytometry. Part B, Clinical cytometry
Rassenti LZ,Kipps TJ
MA1-21350 was used in flow cytometry to discuss the clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemia
Sat Jul 15 00:00:00 EDT 2006
ZAP-70 in CLL: towards standardization of a biomarker for patient management: history of clinical cytometry special issue.
Cytometry. Part B, Clinical cytometry
Marti G,Orfao A,Goolsby C
MA1-21350 was used in flow cytometry to discuss the use of ZAP-70 in chronic lymphocytic leukemia as a biomarker for patient management
Sat Jul 15 00:00:00 EDT 2006
ZAP-70 by flow cytometry: a comparison of different antibodies, anticoagulants, and methods of analysis.
Cytometry. Part B, Clinical cytometry
Best OG,Ibbotson RE,Parker AE,Davis ZA,Orchard JA,Oscier DG
MA1-21350 was used in flow cytometry to discuss the use of ZAP-70 expression to examine chronic lymphocytic leukemia
Sat Jul 15 00:00:00 EDT 2006
Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process.
Cytometry. Part B, Clinical cytometry
Letestu R,Rawstron A,Ghia P,Villamor N,Boeckx N,Boettcher S,Buhl AM,Duerig J,Ibbotson R,Kroeber A,Langerak A,Le Garff-Tavernier M,Mockridge I,Morilla A,Padmore R,Rassenti L,Ritgen M,Shehata M,Smolewski P,Staib P,Ticchioni M,Walker C,Ajchenbaum-Cymbalista F
MA1-21350 was used in flow cytometry to review factors that influences the detection of ZAP-70 by flow cytometry
Sat Jul 15 00:00:00 EDT 2006
An optimized whole blood method for flow cytometric measurement of ZAP-70 protein expression in chronic lymphocytic leukemia.
Cytometry. Part B, Clinical cytometry
Shankey TV,Forman M,Scibelli P,Cobb J,Smith CM,Mills R,Holdaway K,Bernal-Hoyos E,Van Der Heiden M,Popma J,Keeney M
MA1-21350 was used in flow cytometry to review the use of ZAP-70 expression as a biomarker in patients with chronic lymphocytic leukemia
Sat Jul 15 00:00:00 EDT 2006
Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory.
Clinical and laboratory haematology
Gibbs G,Bromidge T,Howe D,Hopkins J,Johnson S
MA1-21350 was used in flow cytometry to measure ZAP-70 in cases of chronic lymphocytic leukemia
Mon Aug 01 00:00:00 EDT 2005